Jean-Pierre Jaffrezou
Affiliations: | 1992- | Stanford University School of Medicine, Palo Alto, CA, United States |
Google:
"Jean-Pierre Jaffrezou"Mean distance: 20.07 (cluster 32)
Collaborators
Sign in to add collaborator| Kevin G. Chen | collaborator | 1992-1994 | Stanford Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen KG, Duran GE, Mogul MJ, et al. (2020) Genomic stability at the coding regions of the multidrug transporter gene : insights into the development of alternative drug resistance mechanisms in human leukemia cells. Cancer Drug Resistance (Alhambra, Calif.). 3: 959-979 |
| Ségui B, Andrieu-Abadie N, Jaffrézou JP, et al. (2006) Sphingolipids as modulators of cancer cell death: potential therapeutic targets. Biochimica Et Biophysica Acta. 1758: 2104-20 |
| Jaffrezou JP, Laurent G. (2004) Ceramide : A New Target in Anticancer Research? Bulletin Du Cancer. 91: E133-61 |
| Dumontet C, Jaffrezou JP, Tsuchiya E, et al. (2004) Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization. Bulletin Du Cancer. 91: E81-112 |
| Grazide S, Terrisse AD, Lerouge S, et al. (2004) Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines. The Journal of Biological Chemistry. 279: 18256-61 |
| Jaffrézou J, Laurent G, Levade T. (2004) Ceramide in Regulation of Apoptosis Sub-Cellular Biochemistry. 36: 269-284 |
| Bezombes C, Laurent G, Jaffrézou JP. (2003) Implication of raft microdomains in drug induced apoptosis. Current Medicinal Chemistry. Anti-Cancer Agents. 3: 263-70 |
| Maestre N, Bezombes C, Plo I, et al. (2003) Phosphatidylcholine-derived phosphatidic acid and diacylglycerol are involved in the signaling pathways activated by docetaxel. Journal of Experimental Therapeutics & Oncology. 3: 36-46 |
| Mas VM, Hernandez H, Plo I, et al. (2003) Protein kinase Czeta mediated Raf-1/extracellular-regulated kinase activation by daunorubicin. Blood. 101: 1543-50 |
| Bezombes C, de Thonel A, Apostolou A, et al. (2002) Overexpression of protein kinase Czeta confers protection against antileukemic drugs by inhibiting the redox-dependent sphingomyelinase activation. Molecular Pharmacology. 62: 1446-55 |